Skip to main content

Table 3 Estimated parameter values for patients 8-15

From: Personalized life expectancy and treatment benefit index of antiretroviral therapy

Par.

P8

P9

P10

P11

P12

P13

P14

P15

β λ

108.12

109.99

127.17

107.15

174.51

112.38

139.62

113.85

β k

1619.24

1444.27

1170.06

1626.31

1586.35

1490.67

1660.41

1576.88

α λ

0.03

0.13

0.22

0.04

0.13

0.06

0.05

0.08

α k

1.18

1.10

0.93

1.09

1.23

1.09

1.17

1.18

T m

3128.4

4026.7

3701.9

3118.1

3254.5

3952.6

4300.6

3220.4

η

0.99

0.87

0.95

0.94

0.96

0.93

0.93

0.95

τ 50

30

30.09

30.71

53.27

30.22

55.79

39.33

65.58

τ m

21897

18753

21340

20003

21530

17541

21454

20267

q

0.55

0.65

0.88

0.58

0.90

0.76

0.53

0.57

p

4.65

4.98

3.25

2.61

3.30

2.11

3.04

2.18

\(\bar {\beta }_{k}\)

746.11

619.94

961.22

189.82

1164.1

1321.1

814

772.8

\(\bar {\alpha }_{k}\)

1.18

1.09

0.87

1.09

1.13

0.93

0.66

1.11

l

0.92

0.86

0.84

0.92

0.83

0.93

0.81

0.93

T s

2441.4

3498.6

3445.7

2472.7

2599.4

3002

3215.7

2569

T r

4526.31

5048.56

4863.17

2872.21

3906.73

4790.24

4418.25

4498.8

T e

7268.8

6339.7

6938.3

5054.7

6722.5

5473

6294.4

4708.4

T d

24338.38

22251.46

24785.25

22476.19

24129.89

20542.58

24669.66

22835.56

B CD4

200

200

150

200

300

300

200

  1. where Par. represents parameter, and Pi denote Patient i